Jitesh Devendra – Trademark Portfolio

Entity Type: 01

Jitesh Devendra holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AXXINOVAR.

1, Jagadeeswaran Street, T.Nagar,

Chennai-600017 Tamil Nadu

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Jitesh Devendra's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Jitesh Devendra have?

Jitesh Devendra has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does Jitesh Devendra file in?

Jitesh Devendra files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Jitesh Devendra's most well-known trademarks?

Jitesh Devendra's registered trademark portfolio includes well-known marks such as AXXINOVAR. These are among 1 currently registered trademark in the portfolio.

What is Jitesh Devendra's trademark registration success rate?

Jitesh Devendra has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.